Latest news

Thumbnail image for Mallinckrodt to split business

Mallinckrodt to split business

UK-based specialty pharma group Mallinckrodt has unveiled plans to spin-off its specialty generics and active pharmaceutical ingredients business into a new company

7th December 2018

Thumbnail image for Norgine launches Shield’s Feraccru in the UK

Norgine launches Shield’s Feraccru in the UK

Norgine has launched Feraccru across the UK to treat patients with iron deficiency anaemia, having picked up rights to sell the drug from Shield Therapeutics earlier this year.

6th December 2018

Thumbnail image for New Vaccines Centre a ‘major commercial opportunity’

New Vaccines Centre a ‘major commercial opportunity’

Business Secretary Greg Clark MP has announced the UK’s first dedicated Vaccines Manufacturing Innovation Centre (VMIC), said to represent a “major commercial opportunity”, and also a new front line in the nation’s defence against global pandemic threats.

5th December 2018

Thumbnail image for Johnson & Johnson pays $300m to develop cusatuzumab

Johnson & Johnson pays $300m to develop cusatuzumab

Johnson & Johnson's Janssen has entered into an agreement potentially worth up to $1.6 billion to develop and market Argenx' cusatuzumab for a number of cancers, including haematological malignancies.

5th December 2018

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download